NeurAxis outlines commercial readiness for 2026 as double-digit growth continues and CPT code milestone nears

Q3 2025 Management View Brian Carrico, President, CEO & Director, emphasized "the continued execution of our commercialization strategy for IB-Stim, our neuromodulation technology for both the ...

CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)

CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 976102026 rates for physician offices, home visits, ...

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption ...

STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as ...

PolarityBio Announces Acceptance of Category III CPT(R) Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT(R) Editorial Panel

PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular therapy, today announced that ...